Advancing European Sovereignty in medical CRBN threats countermeasures: EU R&I Fundings, Challenges, and Strategic Progress
RESILIENCE FRAMEWORK PARTNERSHIP AGREEMENT (FPA)
EUROPEAN AGILE NETWORK FOR MEDICAL COUNTERMEASURES AGAINST CBRN THREATS (COUNTERACT)
Details of the event
7th CBRNe International Conference Research & Innovation
Place: Palais des Congrès Arcachon
Address: Bd Prom. Veyrier Montagnères, 33120 Arcachon
Date: 20th May 2026
Abstract : Since the Covid-19 pandemic and the return of high-intensity warfare to European soil, Europe is strengthening its preparedness and response capabilities against chemical, biological, radiological, and nuclear threats (CRBN). This workshop—co-organised by the two major European Defence Funded initiatives on medical countermeasures R&D (MCMs – vaccines, antidotes, dedicated technologies), RESILIENCE & COUNTERACT, offers a collaborative forum to accelerate this effort. At the heart of the discussions, we will address: the existing funding opportunities at European level, production and stockpiling challenges for the pharmaceutical industry, civil-military cooperation, as well as the first significant scientific results in the field.
RESILIENCE is a framework partnership agreement in which specific grant agreements (seven in total) will be selected within the field of medical countermeasures against CBRN threats. The activities will be specified through a multiannual action plan by RESILIENCE, and the grants will be announced in the corresponding annual EDF work programmes (source: https://defence-industry-space.ec.europa.eu).
Organised by
Hosted by
Acknowledgements: This event has received funding from the European Defence Fund (EDF) under the grant agreement RESILIENCE-R-2023 no.101168024. Funded by the European Union. Views and opinions expressed are those of the author(s) and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the granting authority can be held responsible for them.
08:00-09:00 Registration
9:15-10:00 European funding programs on CBRN MCMs: opportunities for Research and Innovation
Moderated by: Renaud LAFFOURCADE & Téo GÉRAUDIE (CEA)
10:00-10:45 Round Table 1: From laboratory innovation to large-scale production: what strategies are needed to build a sovereign European CBRN medical countermeasures industry?
Moderated by: Fanny CAPUTO & Randa EL FEKIH (CEA)
10:45-11:15 BREAK
11:15-11:30 Presentation of the European CBRN MCM Working Group, by Yannick SAINTIGNY (CEA)
11:30-12:15 Round Table 2: Integrating lessons learned in the military field into CBRN medical research: the role of civil-military cooperation
Moderated by: Ileana AKRICHI and Lou PINCHON CARRON DE LA CARRIÈRE (CEA)
12:15-14:00 LUNCH BREAK
14:00-15:00 Panel 1 - Ongoing projects on radiological & nuclear threats
Moderated by: Yannick SAINTIGNY (CEA)
15:00-15:30 Panel 2 – Transversal research and innovation to CBRN threats
Moderated by: Randa EL FEKIH (CEA)
15:30-16:00 BREAK
16:00-17:00 Panel 3 - Ongoing projects on biological threats
Moderated by: Claudia FILIPPONE (ERINHA)
17:00-18:00 Panel 4 - Ongoing projects on chemical threats
Moderated by: Lou PINCHON CARRON DE LA CARRIÈRE (CEA)
18:00-18:15 Wrap-up and conclusions
Michael ABEND
Marc BENDERITTER
Tim BEAUMONT
Grégoire CHAUVIÈRE LE DRIAN
Luca FIORANI
Marit J. van GILS
Christian HAGGENMILLER
Monique IDIRI
Elin JØRGENSEN
Marina MOLETTA-DENAT
Yannick MOREL (IGA)
Nathalie MORGENSZTEJN
Florian NACHON
Ingars REINHOLDS
Stéphanie SIMON
Jean-Nicolas TOURNIER
Grégory VERNIER
Michel WAKIM
Charles WILLIAMS
Eric ZOLKER
Ileana AKRICHI
Fanny CAPUTO
Randa EL FEKIH
Claudia FILIPPONE
Renaud LAFFOURCADE
Lou PINCHON CARRON DE LA CARRIERE
Yannick SAINTIGNY
Site par White Chapel & ID-Alizés
